Docking and molecular dynamics studies on triclosan derivatives binding to FabI (original) (raw)

• Schäberle TF, Hack IM (2014) Overcoming the current deadlock in antibiotic research. Trends Microbiol 22:165–167
  Article Google Scholar
• Payne DJ, Warren PV, Holmes DJ, Ji Y, Lonsdale JT (2001) Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery. Drug Discov Today 6:537–544
  Article CAS Google Scholar
• Zhang Y-M, White SW, Rock CO (2006) Inhibiting bacterial fatty acid synthesis. J Biol Chem 281:17541–17544
  Article CAS Google Scholar
• Wright HT, Reynolds KA (2007) Antibacterial targets in fatty acid biosynthesis. Curr Opin Microbiol 10:447–453
  Article CAS Google Scholar
• Campbell JW, Cronan JE Jr (2001) Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 55:305–332
  Article CAS Google Scholar
• Chirala SS, Huang W-Y, Jayakumar A, Sakai K, Wakil SJ (1997) Animal fatty acid synthase: functional mapping and cloning and expression of the domain I constituent activities. Proc Natl Acad Sci 94:5588–5593
  Article CAS Google Scholar
• Tsay J-T, Oh W, Larson T, Jackowski S, Rock C (1992) Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. J Biol Chem 267:6807–6814
  CAS Google Scholar
• Clough R, Matthis A, Barnum S, Jaworski J (1992) Purification and characterization of 3-ketoacyl-acyl carrier protein synthase III from spinach. A condensing enzyme utilizing acetyl-coenzyme A to initiate fatty acid synthesis. J Biol Chem 267:20992–20998
  CAS Google Scholar
• Waller RF, Keeling PJ, Donald RG, Striepen B, Handman E, Lang-Unnasch N, Cowman AF, Besra GS, Roos DS, McFadden GI (1998) Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci 95:12352–12357
  Article CAS Google Scholar
• Gerusz V (2010) Recent advances in the inhibition of bacterial fatty acid biosynthesis. Annu Rep Med Chem 45:295–311
  Article CAS Google Scholar
• Heath RJ, Rock CO (1995) Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem 270:26538–26542
  Article CAS Google Scholar
• Heath RJ, Rock CO (2000) Microbiology: a triclosan-resistant bacterial enzyme. Nature 406:145–146
  Article CAS Google Scholar
• Miyakawa S, SUZUKI K, NOTO T, HARADA Y, OKAZAKI H (1982) Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. J Antibiot 35:411–419
  Article CAS Google Scholar
• Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW (1996) A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274:2107–2110
  Article CAS Google Scholar
• Rosner JL (1993) Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid. Antimicrob Agents Chemother 37:2251–2253
  Article CAS Google Scholar
• Winder FG (1982) Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. Biol Mycobacteria 1:353–438
  CAS Google Scholar
• McMurry LM, Oethinger M, Levy SB (1998) Triclosan targets lipid synthesis. Nature 39:4531–532
  Google Scholar
• Heath RJ, Rubin JR, Holland DR, Zhang E, Snow ME, Rock CO (1999) Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 274:11110–11114
  Article CAS Google Scholar
• Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB (1999) Molecular basis of triclosan activity. Nature 398:383–384
  Article CAS Google Scholar
• Qiu X, Janson CA, Smyth MG, Payne DJ, Abdel-Meguid SS (1999) Molecular basis for triclosan activity involves a flipping loop in the active site. Protein Sci 8:2529–2532
  Article CAS Google Scholar
• Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA (1999) Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 38:12514–12525
  Article CAS Google Scholar
• Kumar KR, Rohini P, Md AR, Devi YP (2015) A reviw on occurrence, fate and toxicity of triclosan. World J Pharm Pharm Sci 4:336–369
  CAS Google Scholar
• Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K (2005) Structure-based design, synthesis, and study of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. J Med Chem 48:1596–1609
  Article CAS Google Scholar
• Gerusz V, Denis A, Faivre F, Bonvin Y, Oxoby M, Briet S, LeFralliec Gr, Oliveira C, Desroy N, Raymond Cd (2012) From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria. J Med Chem 55:9914–9928
  Article CAS Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
  Article CAS Google Scholar
• Halgren TA, Nachbar RB (1996) Merck molecular force field. IV. Conformational energies and geometries for MMFF94. J Comput Chem 17:587–615
  CAS Google Scholar
• Halgren TA (1996) Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comput Chem 17:520–552
• Halgren TA (1996) Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J Comput Chem 17:553–586
  Article CAS Google Scholar
• Halgren TA (1996) Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules. J Comput Chem 17:616–641
  Article CAS Google Scholar
• Goodsell DS, Morris GM, Olson AJ (1996) Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 9:1–5
  Article CAS Google Scholar
• Österberg F, Morris GM, Sanner MF, Olson AJ, Goodsell DS (2002) Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins: Struct, Funct, Bioinf 46:34–40
  Article Google Scholar
• Morris GM, Huey R, Olson AJ (2008) Using autodock for ligand‐receptor docking. Curr Protoc Bioinformatics: 24:8.14.1-8.14. 40
• Park H, Lee J, Lee S (2006) Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins: Struct, Funct, Bioinf 65:549–554
  Article CAS Google Scholar
• Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ (2010) Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discovery 5:597–607
  Article CAS Google Scholar
• Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662
  Article CAS Google Scholar
• Fuhrmann J, Rurainski A, Lenhof HP, Neumann D (2010) A new Lamarckian genetic algorithm for flexible ligand‐receptor docking. J Comput Chem 31:1911–1918
  CAS Google Scholar
• Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854
  Article CAS Google Scholar